AACR logo

More articles from Poster Presentations - Late-Breaking Abstracts

Abstract LB-27: Develop mutant isocitrate dehydrogenase 1 (IDH1)-expressing gliomas using RCAS/tv-a technology
Youngmi Kim, Nanna Lindberg, Hamid Bolouri, Jeffrey Delrow, Tatsuya Ozawa, Eric Holland

Cancer Research Oct 2014, 74 (19 Supplement) LB-27; DOI: 10.1158/1538-7445.AM2014-LB-27
Abstract LB-29: Disruption of annexin II tetramer/receptor axis suppresses leukemia cell homing and engraftment
Gopalakrishnapillai Anilkumar, Priyanka Dhanan, Edward A. Kolb, Andrew Napper, Robert Mason, Sonali P. Barwe

Cancer Research Oct 2014, 74 (19 Supplement) LB-29; DOI: 10.1158/1538-7445.AM2014-LB-29
Abstract LB-3: Apolipoprotein (E) is a determinant of colon carcinogenesis potentially by regulating inflammation and β-catenin independently of its role in lipid metabolism
Ali I. Elbahrawy, Abdelmetalab Tarhuni, Amarjit S. Naura, Youssef Errami, Mohamed Alwan, Samar Hammad, Jimena Trillo-Tinoco, Ramadan Hemeida, Hassan Brim, Hassan Ashktorab, Luis Del Valle, Hamid A. Boulares

Cancer Research Oct 2014, 74 (19 Supplement) LB-3; DOI: 10.1158/1538-7445.AM2014-LB-3
Abstract CT419: A phase 1 randomized, open-label, 2-sequence, 2-period crossover study of the effect of multiple doses of palbociclib (PD-0332991) on midazolam pharmacokinetics in healthy women of non-childbearing potential
Justin T. Hoffman, Anna Plotka, Melissa O'Gorman, Cho-Ming Loi, Leonid Kirkovsky, Corrado Gallo-Stampino, Diane Wang

Cancer Research Oct 2014, 74 (19 Supplement) CT419; DOI: 10.1158/1538-7445.AM2014-CT419
Abstract LB-11: Discovery, synthesis, and structure-activity relationship of N-benzyl-2-phenylpyrimidin-4-amine derivatives as potent USP1/UAF1 deubiquitinase inhibitors with anticancer activity against non-small cell lung cancer
Thomas S. Dexheimer, Andrew S. Rosenthal, Diane Luci, Qin Liang, Mark A. Villamil, Ajit Jadhav, Anton Simeonov, Zhihao Zhuang, David J. Maloney

Cancer Research Oct 2014, 74 (19 Supplement) LB-11; DOI: 10.1158/1538-7445.AM2014-LB-11
Abstract LB-35: Living biobank of cancer organoids for drug development and screening
Robert G.J. Vries, Hans Clevers

Cancer Research Oct 2014, 74 (19 Supplement) LB-35; DOI: 10.1158/1538-7445.AM2014-LB-35
Abstract LB-26: Androgen receptor splice variant AR3 promotes prostate cancer via modulating expression of autocrine/paracrine factors
Yun Qiu, Feng Sun, Xi Yang

Cancer Research Oct 2014, 74 (19 Supplement) LB-26; DOI: 10.1158/1538-7445.AM2014-LB-26
Abstract LB-41: Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models
Zsofia Kovaks, Beat Werner, Ernst Martin-Fiori, Michele Bernasconi

Cancer Research Oct 2014, 74 (19 Supplement) LB-41; DOI: 10.1158/1538-7445.AM2014-LB-41
Abstract LB-38: Zebrafish embryos provide a permissive environment for the growth and dissemination of primary human myeloma and its precursor cells
Dongdong MA, Arinze Nwokeji, Jianhong Lin, Yu-Tzu Tai, Nikhil Munshi, Robert I. Handin

Cancer Research Oct 2014, 74 (19 Supplement) LB-38; DOI: 10.1158/1538-7445.AM2014-LB-38
Abstract LB-24: C-terminal PTEN is essential for maintenance of genomic stability and tumor suppression
Wen H. Shen, Yuxin P. Yin

Cancer Research Oct 2014, 74 (19 Supplement) LB-24; DOI: 10.1158/1538-7445.AM2014-LB-24

Main menu

User menu

Search

More articles from Poster Presentations - Late-Breaking Abstracts

Pages

Articles

Info for

About Cancer Research